Developer docs
API playgroundTry for free, no card

Search company profiles

Charlotte's Web

Full company profile

uuid0002256

Namestring
Charlotte's Web
Legal namestring
Charlotte's Web, Inc.
Company typeenum
Public
Founded yearint
2013
Descriptiontext

Charlotte's Web is a publicly-traded hemp-derived wellness company (Toronto Stock Exchange: CWEB; OTCQX: CWBHF) that develops, markets, and distributes CBD and adjacent botanical products. Founded in 2013 in Colorado by the Stanley brothers, the company pioneered the modern CBD category and is headquartered in Louisville, Colorado, with operations across the United States and Canada. Its portfolio spans full-spectrum, broad-spectrum, and THC-free CBD formulations delivered in gummies, oils, soft-gel capsules, topicals, and pet products, with a sub-brand called Brightside that offers low-dose hemp-derived THC Delta 9 gummies and a functional-mushroom gummy line. The company holds a Certified B Corp status, offers USDA-certified organic SKUs, and subjects every batch to third-party laboratory testing with public Certificates of Analysis covering potency, pesticides, heavy metals, mycotoxins, and THC levels.

Underlying technology centers on proprietary full-spectrum hemp extraction and formulation, multi-format delivery systems (gummies, oils, capsules, topicals), and adjunct botanical blends (CBG, CBN, functional mushrooms, adaptogens). Its pharmaceutical exposure comes via DeFloria, Inc., a clinical-stage botanical pharmaceutical company co-founded by Charlotte's Web that is running an FDA Phase 2 program (AJA001) for autism spectrum disorder irritability.

The business model combines direct-to-consumer e-commerce (charlottesweb.com) with a 20–25% subscribe-and-save recurring program, a healthcare-professional channel (CBD Clinic / clinic.charlottesweb.com), B2B wholesale distribution to retailers, and a mass-market retail footprint that expanded to over 800 Walmart stores in 2024. Pricing is unit-based across categories, with individual SKUs ranging from $19.99 (entry-level gummies/pet) to $239.99 (120-count soft-gel bundles). British American Tobacco is the dominant shareholder at approximately 40.6% following a May 2026 recapitalization, and the company is a designated CBD launch partner in the CMS/CMMI Medicare pilot covering up to $500 of CBD annually for eligible Medicare beneficiaries.

Short descriptiontext

Charlotte's Web is a publicly-traded hemp wellness company developing full-spectrum, broad-spectrum, and THC-free CBD products in gummies, oils, capsules, topicals, and pet formats. It serves wellness consumers via DTC e-commerce, 800+ Walmart stores, healthcare professionals, and Medicare pilot programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLouisville, United States
HQ citystring
Louisville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hemp-derived CBD products, CBD wellness products, botanical supplements, hemp extract formulations, cannabinoid wellness products
Industry6 codes
1CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles)
CodeCRANAHAAPrimaryYes
2CBD/Hemp Wellness & Supplements Retail
CodeCRANAHACPrimaryNo
3CBD/Hemp Topicals & Beauty Retail
CodeCRANAHABPrimaryNo
4CBD/Hemp Pet Products Retail
CodeCRANAHAFPrimaryNo
5Hemp-Derived Delta-8/Delta-9/THC-A Specialty Retail (Where Legal)
CodeCRANAHADPrimaryNo
6Hemp & CBD Product Wholesale Distribution
CodeCRAOAIAGPrimaryNo
NAICS code2 codes
  • Food (Health) Supplement Retailers456191
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Hemp-Derived CBD Wellness Products
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Direct Product Sales
TypeSubscription Recurring
Description

One-time and subscription-based sales of CBD wellness products including gummies, oils, capsules, topicals, and pet products through e-commerce and retail channels. Subscription model offers 20-25% recurring discounts to drive customer retention.

charlottesweb.com
2B2B Wholesale Distribution
TypeOne Time License
Description

Wholesale distribution to retail partners including Walmart and other physical retailers, as well as healthcare professional channels through the CBD Clinic practitioner program.

charlottesweb.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1Standard individual product pricing across all categories
ModelUnit PricingBilling cadencePay-as-you-go
Notes

CBD Gummies: $34.99-$49.99; CBD Oils: $44.99-$119.99; Soft Gel Capsules: $74.99-$239.99 (120ct bundles); Topicals: $24.99-$39.99; Pet Products: $19.99-$94.98; THC products: $35.99-$45.99; Mushroom gummies: $19.99-$34.99

charlottesweb.com
2Subscribe & Save program for recurring customers
ModelSubscriptionBilling cadenceMonthly
Notes

25% off first subscription order, then 20% off all recurring orders with free shipping. Available across all product categories.

charlottesweb.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Brightside
Description

Sub-brand for THC Delta 9 products including Knockout (sleep), Unwind, Focus, Daytime, Downtime, Recover, Boost, and Anytime low-dose THC gummies

newswire.ca
+1 more record
Core offering1 text field

Charlotte's Web develops, manufactures, and distributes hemp-derived cannabidiol (CBD) wellness products in multiple delivery formats including ingestible gummies, oils, and soft gel capsules, topical creams and balms, and pet supplements. The company has expanded into functional mushroom gummies and a Brightside sub-brand offering low-dose hemp-derived THC Delta 9 gummies for sleep, calm, focus, energy, and recovery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Third-party testing confirms CBD potency aligned with label claims (Forbes Health commissioned testing found 13.6mg vs labeled 15mg)
+2 more records
Product overview1 text field

Charlotte's Web is a hemp-derived wellness company offering a diversified portfolio of CBD and botanical products centered around its proprietary full-spectrum hemp extracts. The core product line includes ingestible formats (CBD oils, gummies, and soft gel capsules), topical applications (creams, balms, and cooling gels), and pet wellness products. The company has expanded into functional mushroom gummies and a THC Delta 9 sub-brand called Brightside offering low-dose hemp-derived THC products. The product portfolio is organized around wellness benefits including Sleep, Calm & Stress, Focus, Recovery & Pain, Energy, and Daily Wellness, with ingredient variations including Full-Spectrum CBD, THC-Free (broad-spectrum), THC Delta 9, and Functional Mushrooms.

Product and service6 records
1CBD Gummies
CategoryCBD Gummies
Description

Full-spectrum and THC-free broad-spectrum CBD gummies formulated for specific wellness outcomes including sleep (with melatonin or CBN), calm and stress, focus, daily wellness, brain support, muscle recovery, and energy and endurance. Sold in 25-60 count bottles.

2CBD Oils
CategoryCBD Oils
Description

Full-spectrum, broad-spectrum, and THC-free CBD tincture oils in 17mg, 25mg, 50mg, and 60mg strengths, including the company's flagship Original Formula, for sublingual daily wellness use.

3CBD Soft Gel Capsules
CategoryCBD Capsules
Description

Pre-measured full-spectrum CBD soft gel capsules providing precise dosing in convenient on-the-go format. Available in daily care and premium 120-count bundles.

4CBD Topicals
CategoryCBD Topicals
Description

Full-spectrum and broad-spectrum CBD topical products including cream, balm, balm stick, cooling gel, and THC-free soothing cream, designed for targeted relief of muscles and joints.

5Functional Mushroom Gummies
CategoryFunctional Mushroom Gummies
Description

Functional mushroom gummies combining adaptogens like Reishi and Ashwagandha for sleep, stress support, focus, energy, and muscle restoration.

6Brightside THC Delta 9 Gummies
CategoryTHC Delta 9 Gummies
Description

Brightside sub-brand offering low-dose hemp-derived THC Delta 9 gummies for sleep, calm, focus, energy, recovery, and anytime use, with fast-onset effects.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-05
Description

Clinical-stage botanical pharmaceutical company in which Charlotte's Web is a co-founder and shareholder. Charlotte's Web co-founder Jared Stanley now serves as CEO of DeFloria. Collaboration includes FDA Phase 2 AJA001 program for autism spectrum disorder irritability, leveraging Charlotte's Web cultivation and regulatory expertise.

TypeOthersAnnounced on2026-03-23
Description

Federal healthcare agency finalizing rule to offer Medicare coverage for hemp-derived CBD products through pilot program. Charlotte's Web collaborating with CMS on program design, which defines eligible products as orally administered hemp products containing up to 3mg per serving of tetrahydrocannabinols.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-18
Description

Charlotte's Web is a CBD launch partner in the CMS Substance Access Beneficiary Engagement Incentive pilot program launching April 1, 2026. Program will cover up to $500 of hemp-derived CBD products annually for eligible Medicare beneficiaries, focusing initially on senior cancer patients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-18
Description

Non-profit organization coordinating care and support services for the CMS Medicare pilot program for senior cancer patients, integrating Charlotte's Web CBD products with comprehensive care coordination.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pharmaceutical development collaboration through DeFloria partnership for clinical-stage botanical pharmaceutical pipeline development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Vertically-integrated CBD brand with a broad tincture/edible/topical catalog and a strong value-assistance program for veterans, low-income, and disabled customers. Comparable scale and direct-to-consumer orientation.

TypeDirect peer
Description

Direct publicly-traded peer operating the PlusCBD Oil brand across oils, gummies, topicals, and pet products. Closest comparable in business model, channel mix (DTC + mass retail), and category positioning to Charlotte's Web.

TypeDirect peer
Description

Publicly-traded CBD wellness company with a comparable portfolio of tinctures, gummies, topicals, sleep/calm SKUs, and pet products sold via DTC and Amazon. Similar scale and price-band positioning.

TypeEmerging player
Description

Niche CBD brand focused on sleep, calm, and recovery gummies with a primarily DTC subscription model. Smaller and narrower than Charlotte's Web but increasingly competitive in the same gummy subcategory.

TypeDirect peer
Description

Pharmacist-formulated CBD brand (now owned by The Valens Company) selling oils, gummies, topicals and pet products. Closely comparable positioning as a wellness-forward, pharmacist-formulated competitor.

TypeDirect peer
Description

CBD wellness brand offering tinctures, capsules, topicals, sleep and immunity SKUs. Comparable product breadth and quality-assurance emphasis (third-party testing, COA transparency) similar to Charlotte's Web.

TypeBroad incumbent
Description

Canadian-licensed cannabis producer with consumer wellness SKUs and CBD derivative products. Broad incumbent overlap rather than direct competition, but relevant for cross-border CBD category economics.

TypeBroad incumbent
Description

Major cannabis operator with CBD wellness products (historically Martha Stewart CBD, First+Free) plus nutraceutical adjacencies. Much larger and broader portfolio, but adjacent on consumer CBD wellness where Charlotte's Web plays.

TypeBroad incumbent
Description

Large diversified cannabis/hemp conglomerate with overlapping wellness, beverage, and edible product lines via brands like Manitoba Harvest. Operates at much larger scale and broader portfolio than Charlotte's Web but competes for the same shelf and consumer wallet share.

TypeDirect peer
Description

Global hemp-derived CBD brand with comparable ingestible and topical offerings, distributed across the US, Europe, and Asia-Pacific. Similar scale and cross-channel mix to Charlotte's Web.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Charlotte's Web

Hemp-Derived CBD Wellness Productscharlottesweb.com

Charlotte's Web is a publicly-traded hemp wellness company developing full-spectrum, broad-spectrum, and THC-free CBD products in gummies, oils, capsules, topicals, and pet formats. It serves wellness consumers via DTC e-commerce, 800+ Walmart stores, healthcare professionals, and Medicare pilot programs.

What Charlotte's Web does

Charlotte's Web is a publicly-traded hemp-derived wellness company (Toronto Stock Exchange: CWEB; OTCQX: CWBHF) that develops, markets, and distributes CBD and adjacent botanical products. Founded in 2013 in Colorado by the Stanley brothers, the company pioneered the modern CBD category and is headquartered in Louisville, Colorado, with operations across the United States and Canada. Its portfolio spans full-spectrum, broad-spectrum, and THC-free CBD formulations delivered in gummies, oils, soft-gel capsules, topicals, and pet products, with a sub-brand called Brightside that offers low-dose hemp-derived THC Delta 9 gummies and a functional-mushroom gummy line. The company holds a Certified B Corp status, offers USDA-certified organic SKUs, and subjects every batch to third-party laboratory testing with public Certificates of Analysis covering potency, pesticides, heavy metals, mycotoxins, and THC levels.

Underlying technology centers on proprietary full-spectrum hemp extraction and formulation, multi-format delivery systems (gummies, oils, capsules, topicals), and adjunct botanical blends (CBG, CBN, functional mushrooms, adaptogens). Its pharmaceutical exposure comes via DeFloria, Inc., a clinical-stage botanical pharmaceutical company co-founded by Charlotte's Web that is running an FDA Phase 2 program (AJA001) for autism spectrum disorder irritability.

The business model combines direct-to-consumer e-commerce (charlottesweb.com) with a 20–25% subscribe-and-save recurring program, a healthcare-professional channel (CBD Clinic / clinic.charlottesweb.com), B2B wholesale distribution to retailers, and a mass-market retail footprint that expanded to over 800 Walmart stores in 2024. Pricing is unit-based across categories, with individual SKUs ranging from $19.99 (entry-level gummies/pet) to $239.99 (120-count soft-gel bundles). British American Tobacco is the dominant shareholder at approximately 40.6% following a May 2026 recapitalization, and the company is a designated CBD launch partner in the CMS/CMMI Medicare pilot covering up to $500 of CBD annually for eligible Medicare beneficiaries.

Charlotte's Web firmographics

Firmographics
Name
Charlotte's Web
Legal name
Charlotte's Web, Inc.
Website
https://charlottesweb.com
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
101–250 employees
Short description
Charlotte's Web is a publicly-traded hemp wellness company developing full-spectrum, broad-spectrum, and THC-free CBD products in gummies, oils, capsules, topicals, and pet formats. It serves wellness consumers via DTC e-commerce, 800+ Walmart stores, healthcare professionals, and Medicare pilot programs.
Ownership category
akta.pro rank

Charlotte's Web industry classification

Industry
Product category
Hemp-Derived CBD Wellness Products
NAICS
Food (Health) Supplement Retailers (456191), Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro primary industry
CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA)
akta.pro secondary industries
CBD/Hemp Wellness & Supplements Retail (CRANAHAC), CBD/Hemp Topicals & Beauty Retail (CRANAHAB), CBD/Hemp Pet Products Retail (CRANAHAF), Hemp-Derived Delta-8/Delta-9/THC-A Specialty Retail (Where Legal) (CRANAHAD), Hemp & CBD Product Wholesale Distribution (CRAOAIAG)

Keywords

  • Hemp-derived CBD products
  • CBD wellness products
  • Botanical supplements
  • Hemp extract formulations
  • Cannabinoid wellness products

Where Charlotte's Web is headquartered

Location

Headquarters

HQ city
Louisville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Charlotte's Web business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Direct Product Sales: One-time and subscription-based sales of CBD wellness products including gummies, oils, capsules, topicals, and pet products through e-commerce and retail channels. Subscription model offers 20-25% recurring discounts to drive customer retention.
  2. B2B Wholesale Distribution: Wholesale distribution to retail partners including Walmart and other physical retailers, as well as healthcare professional channels through the CBD Clinic practitioner program.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard individual product pricing across all categories
SubscriptionMonthlySubscribe & Save program for recurring customers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Charlotte's Web product offering

Product offering

Core offering

Charlotte's Web develops, manufactures, and distributes hemp-derived cannabidiol (CBD) wellness products in multiple delivery formats including ingestible gummies, oils, and soft gel capsules, topical creams and balms, and pet supplements. The company has expanded into functional mushroom gummies and a Brightside sub-brand offering low-dose hemp-derived THC Delta 9 gummies for sleep, calm, focus, energy, and recovery.

Product overview

Charlotte's Web is a hemp-derived wellness company offering a diversified portfolio of CBD and botanical products centered around its proprietary full-spectrum hemp extracts. The core product line includes ingestible formats (CBD oils, gummies, and soft gel capsules), topical applications (creams, balms, and cooling gels), and pet wellness products. The company has expanded into functional mushroom gummies and a THC Delta 9 sub-brand called Brightside offering low-dose hemp-derived THC products. The product portfolio is organized around wellness benefits including Sleep, Calm & Stress, Focus, Recovery & Pain, Energy, and Daily Wellness, with ingredient variations including Full-Spectrum CBD, THC-Free (broad-spectrum), THC Delta 9, and Functional Mushrooms.

Differentiator

Problem solved

Functional benefit

Brands

  • Brightside: Sub-brand for THC Delta 9 products including Knockout (sleep), Unwind, Focus, Daytime, Downtime, Recover, Boost, and Anytime low-dose THC gummies
  • CBD Clinic

Products and services

  • CBD Gummies Full-spectrum and THC-free broad-spectrum CBD gummies formulated for specific wellness outcomes including sleep (with melatonin or CBN), calm and stress, focus, daily wellness, brain support, muscle recovery, and energy and endurance. Sold in 25-60 count bottles.
  • CBD Oils Full-spectrum, broad-spectrum, and THC-free CBD tincture oils in 17mg, 25mg, 50mg, and 60mg strengths, including the company's flagship Original Formula, for sublingual daily wellness use.
  • CBD Soft Gel Capsules Pre-measured full-spectrum CBD soft gel capsules providing precise dosing in convenient on-the-go format. Available in daily care and premium 120-count bundles.
  • CBD Topicals Full-spectrum and broad-spectrum CBD topical products including cream, balm, balm stick, cooling gel, and THC-free soothing cream, designed for targeted relief of muscles and joints.
  • Functional Mushroom Gummies Functional mushroom gummies combining adaptogens like Reishi and Ashwagandha for sleep, stress support, focus, energy, and muscle restoration.
  • Brightside THC Delta 9 Gummies Brightside sub-brand offering low-dose hemp-derived THC Delta 9 gummies for sleep, calm, focus, energy, recovery, and anytime use, with fast-onset effects.

Quantifiable outcome

  • Third-party testing confirms CBD potency aligned with label claims (Forbes Health commissioned testing found 13.6mg vs labeled 15mg)
  • +2 more outcomes

Companies that use Charlotte's Web

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles5 records

Charlotte's Web technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Charlotte's Web partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • DeFloria, Inc.coreStrategic or Co-development Partner · 5 June 2026Clinical-stage botanical pharmaceutical company in which Charlotte's Web is a co-founder and shareholder. Charlotte's Web co-founder Jared Stanley now serves as CEO of DeFloria. Collaboration includes FDA Phase 2 AJA001 program for autism spectrum disorder irritability, leveraging Charlotte's Web cultivation and regulatory expertise.
  • Centers for Medicare & Medicaid Services (CMS)Others · 23 March 2026Federal healthcare agency finalizing rule to offer Medicare coverage for hemp-derived CBD products through pilot program. Charlotte's Web collaborating with CMS on program design, which defines eligible products as orally administered hemp products containing up to 3mg per serving of tetrahydrocannabinols.
  • Center for Medicare and Medicaid Innovation (CMMI)coreStrategic or Co-development Partner · 18 December 2025Charlotte's Web is a CBD launch partner in the CMS Substance Access Beneficiary Engagement Incentive pilot program launching April 1, 2026. Program will cover up to $500 of hemp-derived CBD products annually for eligible Medicare beneficiaries, focusing initially on senior cancer patients.
  • Realm of CaringcoreStrategic or Co-development Partner · 18 December 2025Non-profit organization coordinating care and support services for the CMS Medicare pilot program for senior cancer patients, integrating Charlotte's Web CBD products with comprehensive care coordination.
  • Ajna BioSciencesminorStrategic or Co-development PartnerPharmaceutical development collaboration through DeFloria partnership for clinical-stage botanical pharmaceutical pipeline development.

Scale indicators7 records

Recent moves6 records

Expansion highlights7 records

Charlotte's Web competitors and assessment

Company assessment

Direct peers

  • Lazarus Naturals: Vertically-integrated CBD brand with a broad tincture/edible/topical catalog and a strong value-assistance program for veterans, low-income, and disabled customers. Comparable scale and direct-to-consumer orientation.
  • CV Sciences (formerly CannaVest): Direct publicly-traded peer operating the PlusCBD Oil brand across oils, gummies, topicals, and pet products. Closest comparable in business model, channel mix (DTC + mass retail), and category positioning to Charlotte's Web.
  • cbdMD: Publicly-traded CBD wellness company with a comparable portfolio of tinctures, gummies, topicals, sleep/calm SKUs, and pet products sold via DTC and Amazon. Similar scale and price-band positioning.
  • Green Roads: Pharmacist-formulated CBD brand (now owned by The Valens Company) selling oils, gummies, topicals and pet products. Closely comparable positioning as a wellness-forward, pharmacist-formulated competitor.
  • Medterra: CBD wellness brand offering tinctures, capsules, topicals, sleep and immunity SKUs. Comparable product breadth and quality-assurance emphasis (third-party testing, COA transparency) similar to Charlotte's Web.
  • Elixinol: Global hemp-derived CBD brand with comparable ingestible and topical offerings, distributed across the US, Europe, and Asia-Pacific. Similar scale and cross-channel mix to Charlotte's Web.

Emerging players

  • Highline Wellness: Niche CBD brand focused on sleep, calm, and recovery gummies with a primarily DTC subscription model. Smaller and narrower than Charlotte's Web but increasingly competitive in the same gummy subcategory.

Broad incumbents

  • Aurora Cannabis: Canadian-licensed cannabis producer with consumer wellness SKUs and CBD derivative products. Broad incumbent overlap rather than direct competition, but relevant for cross-border CBD category economics.
  • Canopy Growth Corporation: Major cannabis operator with CBD wellness products (historically Martha Stewart CBD, First+Free) plus nutraceutical adjacencies. Much larger and broader portfolio, but adjacent on consumer CBD wellness where Charlotte's Web plays.
  • Tilray Brands: Large diversified cannabis/hemp conglomerate with overlapping wellness, beverage, and edible product lines via brands like Manitoba Harvest. Operates at much larger scale and broader portfolio than Charlotte's Web but competes for the same shelf and consumer wallet share.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Charlotte's Web social profiles

Digital presence

Charlotte's Web compliance and trust

Trust signal

Compliance3 records

Charlotte's Web financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Charlotte's Web leadership team

Management profile

Number of profiles

Profiles7 records

Charlotte's Web subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Charlotte's Web funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Charlotte's Web M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Charlotte's Web

What does Charlotte's Web do?

Charlotte's Web develops, manufactures, and distributes hemp-derived cannabidiol (CBD) wellness products in multiple delivery formats including ingestible gummies, oils, and soft gel capsules, topical creams and balms, and pet supplements. The company has expanded into functional mushroom gummies and a Brightside sub-brand offering low-dose hemp-derived THC Delta 9 gummies for sleep, calm, focus, energy, and recovery.

Is Charlotte's Web a public or private company?

Charlotte's Web is a public company. It is classified as public and is currently operating.

When was Charlotte's Web founded?

Charlotte's Web was founded in 2013. It employs 101 to 250 people.

Where is Charlotte's Web based?

Charlotte's Web is headquartered in Louisville, United States, in the North America region.

How does Charlotte's Web make money?

Two revenue lines are on record. Direct Product Sales are the primary driver. The others are B2B Wholesale Distribution.

Who are Charlotte's Web's main competitors?

Direct peers on record are Lazarus Naturals, CV Sciences (formerly CannaVest), cbdMD, Green Roads, Medterra and Elixinol. Highline Wellness is listed as an emerging player. Broad incumbents are Aurora Cannabis, Canopy Growth Corporation and Tilray Brands.

Does Charlotte's Web have an API?

No public API is recorded for Charlotte's Web.

What industry is Charlotte's Web in?

Charlotte's Web's product category is Hemp-Derived CBD Wellness Products. Its primary akta.pro industry code is CRANAHAA, CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles), with a secondary code of CRANAHAC, CBD/Hemp Wellness & Supplements Retail. Its NAICS code is 456191 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestCharlotte's Web: Route CBD Is Advocacy, Not a Revenue Fix — Hold for the December Hemp VoteCharlotte's Web Holdings launched 'Route CBD,' a cross-border advocacy tour in Nevada to maintain product access for California consumers following the state's implementation of restrictive hemp laws on July 1. The company faces a significant revenue decline, with California accounting for roughly 10% of sales, while its financial health has stabilized through debt conversion and an equity injection from British American Tobacco. The stock remains rated Hold as investors await a critical federal hemp policy decision scheduled for December 11, which will determine the long-term viability of full-spectrum hemp products.Marijuana MomentSenate candidates clash on cannabis (Newsletter: August 17, 2026)This newsletter aggregates multiple developments in the cannabis sector, including Senate candidates clashing over marijuana policy, a Massachusetts ballot measure threatening to roll back legalization, and new court rulings in North Carolina and Virginia regarding hemp and search warrants. Key financial reports from Glass House Brands Inc. and Charlotte’s Web Holdings Inc. revealed continued net losses despite revenue generation, while regulatory updates were issued across several U.S. states.Markets DailyCharlotte’s Web (TSE:CWEB) Shares Up 3.8% – Still a Buy?Charlotte’s Web Holdings Inc. shares rose 3.8% to close at C$0.41 on Thursday, trading below its two-hundred-day moving average of C$0.68. The company recently reported a quarterly loss of C$0.03 per share with revenue of C$15.42 million and maintains a negative net margin of 74.93%. Analysts forecast a slight positive EPS of approximately 0.0029 for the current year.Quiver QuantitativeCharlotte’s Web Q2 Revenue Falls 15.2% as Net Loss Narrows | CWBHF Stock NewsCharlotte’s Web Holdings Inc. reported a 15.2% decline in second-quarter 2026 revenue to $10.9 million, attributed to its retail channel restructuring efforts. However, the company's net loss narrowed to $4.1 million from $6.3 million in the prior year, supported by a reduction in total liabilities following the conversion of BAT’s convertible debenture and a $10 million private placement.YahooCharlotte's Web Reports Second Quarter 2026 Financial ResultsCharlotte's Web Holdings reported its second quarter 2026 financial results, highlighting a recapitalization that eliminated its largest liability and restored positive shareholders' equity. The company also achieved a gross margin expansion to 47.5% and reduced operating cash use to $0.9 million following strategic channel decisions. Additionally, the firm noted significant federal hemp policy movements, including legislative efforts and administrative interventions aimed at protecting non-intoxicating full-spectrum hemp products.FmiblogBroad Spectrum CBD Gummies Market to Reach USD 982.4 Million by 2036 as THC-Free Wellness Demand and Direct-to-Consumer Education Accelerate GrowthFuture Market Insights projects the global broad spectrum CBD gummies market to grow from USD 486.2 million in 2025 to USD 982.4 million by 2036, driven by demand for THC-free wellness products and direct-to-consumer sales. Key players such as cbdMD Inc., Charlotte’s Web Holdings Inc., and Medterra CBD LLC are competing on product transparency, testing, and compliant labeling amid regulatory scrutiny. The United States is identified as the fastest-growing major market with a 7.8% CAGR, followed by Canada and the United Kingdom.FinanzNachrichten.deMMJ International Holdings: Dr. Oz's Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte's Web Hemp ExtractMMJ International Holdings publicly called on CMS Administrator Dr. Mehmet Oz and the Centers for Medicare & Medicaid Services to explain why the federal government is expanding Medicare access to hemp-derived CBD products that have not completed the FDA drug-development process required for pharmaceutical medicines. The company pointed to a March 2026 European Food Safety Authority scientific opinion finding that safety could not be established for a Charlotte's Web hemp extract due to uncharacterized material and inadequate stability and toxicological evidence. MMJ, which has spent over eight years and $10 million pursuing FDA approval for its own pharmaceutical cannabinoid product under clinical hold, questioned why CMS is facilitating commercial hemp access for chronically ill Medicare beneficiaries without requiring the same scientific standards applied to drug developers.YahooCharlotte's Web Welcomes Senate Passage of Hemp Extension Marking Important Progress Toward a Long-Term Federal Hemp FrameworkThe U.S. Senate passed a Continuing Resolution extending government funding and delaying legislation that would restrict hemp products to 0.4 mg THC by November 2026. Charlotte's Web Holdings, Inc. welcomed this development, which maintains access to full-spectrum hemp CBD products while Congress finalizes a long-term regulatory framework.NewsfileCharlotte's Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product AccessCharlotte's Web Holdings announced that California's new SB 378 regulations, effective July 1, 2026, will significantly restrict the sale of ingestible full-spectrum and broad-spectrum hemp-derived products, forcing the company to cease direct-to-consumer shipments to California consumers. The company's CEO described the restriction as a tragedy for families who rely on these products, warning it could create a public health crisis by removing safe, trusted options. The state-level restriction contrasts with federal momentum, as the White House recently called on Congress to revise federal hemp regulations to preserve access to full-spectrum CBD products and referenced bipartisan legislation by Representative Andy Barr.Stock TitanCharlotte's Web to halt California hemp shipments July 1Charlotte's Web Holdings, Inc. announced it must cease direct-to-consumer shipments of ingestible full-spectrum and broad-spectrum hemp-derived products to California consumers beginning July 1, 2026, due to new state regulations under SB 378 that are among the most restrictive in the nation. California's action directly conflicts with the federal Administration's June 24, 2026 call for Congress to preserve consumer access to full-spectrum hemp products, creating divergent federal and state regulatory paths. The company, which maintains it will continue advocating for consumer access at both levels, expects topical products and isolates to remain available in California pending regulatory confirmation.